Total Payments
$17,453
2024 Payments
$11,764
Companies
27
Transactions
92
Medicare Patients
348
Medicare Billing
$45,663
Payment Breakdown by Category
Other$8,933 (51.2%)
Consulting$3,053 (17.5%)
Food & Beverage$2,067 (11.8%)
Travel$1,900 (10.9%)
Research$1,500 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,933 | 5 | 51.2% |
| Consulting Fee | $3,053 | 3 | 17.5% |
| Food and Beverage | $2,067 | 79 | 11.8% |
| Travel and Lodging | $1,900 | 4 | 10.9% |
| Unspecified | $1,500 | 1 | 8.6% |
Payments by Type
General
$15,953
91 transactions
Research
$1,500
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $11,254 | 24 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,488 | 1 | $0 (2017) |
| AbbVie Inc. | $1,629 | 3 | $0 (2021) |
| Dr.Reddy's Laboratories,Inc. | $362.00 | 1 | $0 (2024) |
| Shire North American Group Inc | $275.54 | 4 | $0 (2018) |
| Novo Nordisk Inc | $239.68 | 3 | $0 (2024) |
| BAXTER HEALTHCARE | $203.00 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $180.79 | 14 | $0 (2022) |
| TG Therapeutics, Inc. | $124.99 | 1 | $0 (2023) |
| Braintree Laboratories, Inc. | $105.92 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,764 | 32 | Phathom Pharmaceuticals, Inc. ($11,254) |
| 2023 | $138.65 | 2 | TG Therapeutics, Inc. ($124.99) |
| 2022 | $29.07 | 2 | Braintree Laboratories, Inc. ($15.71) |
| 2021 | $246.28 | 11 | AbbVie Inc. ($108.00) |
| 2020 | $1,515 | 2 | AbbVie Inc. ($1,500) |
| 2019 | $274.25 | 6 | BAXTER HEALTHCARE ($203.00) |
| 2018 | $388.84 | 14 | Shire North American Group Inc ($225.00) |
| 2017 | $3,097 | 23 | Otsuka America Pharmaceutical, Inc. ($2,488) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $629.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Gastroenterology | ||||||
| 10/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/21/2024 | Dr.Reddy's Laboratories,Inc. | — | Consulting Fee | Cash or cash equivalent | $362.00 | General |
| 09/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $104.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $55.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $777.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $346.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $41.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $146.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $78.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 93 | 128 | $43,650 | $12,504 |
| 2022 | 4 | 91 | 119 | $42,500 | $12,670 |
| 2021 | 4 | 114 | 145 | $49,800 | $14,860 |
| 2020 | 2 | 50 | 73 | $12,800 | $5,629 |
Total Patients
348
Total Services
465
Medicare Billing
$45,663
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $12,800 | $4,510 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 32 | $6,400 | $3,185 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 35 | $5,250 | $2,716 | 51.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $16,500 | $1,077 | 6.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 16 | 18 | $2,700 | $1,016 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $12,450 | $4,598 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 34 | $5,100 | $2,761 | 54.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 19 | $3,800 | $2,171 | 57.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $18,000 | $1,926 | 10.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 21 | $3,150 | $1,215 | 38.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 41 | $8,200 | $4,785 | 58.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $9,200 | $3,463 | 37.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 37 | $5,550 | $3,055 | 55.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 15 | 15 | $22,500 | $1,842 | 8.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 26 | 29 | $4,350 | $1,715 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 37 | $7,400 | $3,510 | 47.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 36 | $5,400 | $2,120 | 39.3% |
About Dr. Devang Patel, MD
Dr. Devang Patel, MD is a Gastroenterology healthcare provider based in South Plainfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558395046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devang Patel, MD has received a total of $17,453 in payments from pharmaceutical and medical device companies, with $11,764 received in 2024. These payments were reported across 92 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,933).
As a Medicare-enrolled provider, Patel has provided services to 348 Medicare beneficiaries, totaling 465 services with total Medicare billing of $45,663. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location South Plainfield, NJ
- Active Since 07/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1558395046
Products in Payments
- VOQUEZNA (Drug) $11,254
- BREATHTEK (Device) $2,488
- IPS - Non Product Related (Biological) $203.00
- BRIUMVI (Drug) $124.99
- RINVOQ (Biological) $108.00
- Victoza (Drug) $106.48
- Amitiza (Drug) $105.06
- Tresiba (Drug) $99.12
- XIFAXAN (Drug) $92.06
- LINZESS (Drug) $78.81
- SUPREP (Drug) $76.17
- TRULANCE (Drug) $67.28
- SUCRAID (Drug) $44.53
- Motegrity (Drug) $42.29
- PENTASA (Drug) $39.16
- Trulance (Drug) $38.29
- ENSITE (Device) $36.84
- SUTAB (Drug) $29.75
- Dexilant (Drug) $27.66
- MOTEGRITY (Drug) $27.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.